Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
(-)-englerin A + JQ1
|
DC8RL9H
|
(-)-englerin A
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
ABT-199 + JQ1
|
DC65KCR
|
ABT-199
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
ABT-263 + JQ1
|
DCSNW9A
|
ABT-263
|
Ewing sarcoma (Cell Line: TC-71)
|
[3] |
Afatinib + JQ1
|
DCSP0SS
|
Afatinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
AT7519 + JQ1
|
DC4MCSR
|
AT7519
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
ATI-17000 + JQ1
|
DCAV5CD
|
ATI-17000
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
AZD8055 + JQ1
|
DC0I3UN
|
AZD8055
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
AZD8330 + JQ1
|
DCR4TIG
|
AZD8330
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Bafilomycin A1 + JQ1
|
DCYTHU4
|
Bafilomycin A1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Bardoxolone methyl + JQ1
|
DC6Q2IK
|
Bardoxolone methyl
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Belinostat + JQ1
|
DCLHWO2
|
Belinostat
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[3] |
Belinostat + JQ1
|
DCI7TZR
|
Belinostat
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[3] |
Belinostat + JQ1
|
DC4YRLQ
|
Belinostat
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[3] |
BGJ398 + JQ1
|
DCJIVPA
|
BGJ398
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[3] |
BGJ398 + JQ1
|
DCUFEZC
|
BGJ398
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[3] |
BMS-754807 + JQ1
|
DCUXPF0
|
BMS-754807
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
BMS-754807 + JQ1
|
DCYUI3F
|
BMS-754807
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
BMS-754807 + JQ1
|
DCTS3NH
|
BMS-754807
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
BMS-754807 + JQ1
|
DCWXF5Y
|
BMS-754807
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
Buparlisib + JQ1
|
DC12CEJ
|
Buparlisib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CA4P + JQ1
|
DCO26JX
|
CA4P
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + JQ1
|
DCU06XJ
|
CA4P
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Carfilzomib + JQ1
|
DC9BWGL
|
Carfilzomib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
Carfilzomib + JQ1
|
DCZ39N1
|
Carfilzomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Ceritinib + JQ1
|
DC1GI3P
|
Ceritinib
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[3] |
Ceritinib + JQ1
|
DCR4V0P
|
Ceritinib
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[3] |
CF102 + JQ1
|
DCVCNOI
|
CF102
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Dasatinib + JQ1
|
DCQBYOJ
|
Dasatinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Erlotinib + JQ1
|
DCNG14S
|
Erlotinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Evacetrapib + JQ1
|
DC1K5OB
|
Evacetrapib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Everolimus + JQ1
|
DC9SOGG
|
Everolimus
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
Everolimus + JQ1
|
DC6SJF4
|
Everolimus
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
Everolimus + JQ1
|
DC5D4JM
|
Everolimus
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
Everolimus + JQ1
|
DC7O1KK
|
Everolimus
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Flavopiridol + JQ1
|
DC0KNR8
|
Flavopiridol
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
Fostamatinib + JQ1
|
DC83XBH
|
Fostamatinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
GSK2126458 + JQ1
|
DCBPIX1
|
GSK2126458
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[3] |
GSK2126458 + JQ1
|
DCA1K6M
|
GSK2126458
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[3] |
IMD-0354 + JQ1
|
DCXA4PR
|
IMD-0354
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
JQ1 + Epothilone D
|
DCIIJA2
|
Epothilone D
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Ombrabulin
|
DCXI9F0
|
Ombrabulin
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + AT13387
|
DCWP5X7
|
AT13387
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
JQ1 + AT13387
|
DCXJIS9
|
AT13387
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Trametinib
|
DCQON09
|
Trametinib
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
JQ1 + Trametinib
|
DC3OV52
|
Trametinib
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
JQ1 + Trametinib
|
DCGUSF6
|
Trametinib
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
JQ1 + JQ1
|
DCML9LO
|
JQ1
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
JQ1 + JQ1
|
DC2HU66
|
JQ1
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
JQ1 + Carfilzomib
|
DC5FTDR
|
Carfilzomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
JQ1 + Panobinostat
|
DC7XMB9
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
JQ1 + Ixazomib
|
DCOBPZE
|
Ixazomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
JQ1 + Eltanexor oral
|
DCKOQVR
|
Eltanexor oral
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Everolimus
|
DCHT1GS
|
Everolimus
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + GDC-0084
|
DCYS331
|
GDC-0084
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Cantharidin
|
DCL3Y4P
|
Cantharidin
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Exherin
|
DC3Y0UZ
|
Exherin
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + THAPSIGARGIN
|
DC9J1WC
|
THAPSIGARGIN
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
JQ1 + THAPSIGARGIN
|
DCG95YV
|
THAPSIGARGIN
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Etoposide
|
DCO2KAV
|
Etoposide
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + PHA-739358
|
DCDNYYN
|
PHA-739358
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Mitomycin
|
DC6SOCF
|
Mitomycin
|
Diffuse large B cell lymphoma (Cell Line: TMD8)
|
[2] |
JQ1 + SNX-5422
|
DC7BWUL
|
SNX-5422
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + AS602868
|
DCXEB2O
|
AS602868
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
JQ1 + Tamoxifen
|
DCYQ995
|
Tamoxifen
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
JQ1 + Nintedanib
|
DCPPAQK
|
Nintedanib
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Tivantinib
|
DCORMXU
|
Tivantinib
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + (-)-englerin A
|
DCB5F80
|
(-)-englerin A
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + MK-2206
|
DC2BNQF
|
MK-2206
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
JQ1 + MK-2206
|
DC6Y2ID
|
MK-2206
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
JQ1 + MK-2206
|
DC4856K
|
MK-2206
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + CHS-828
|
DC8EPRF
|
CHS-828
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + LY2874455
|
DCK29BS
|
LY2874455
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
JQ1 + Cytarabine
|
DC6SD56
|
Cytarabine
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Larotrectinib + JQ1
|
DCJT9I6
|
Larotrectinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
LY2874455 + JQ1
|
DCYKKPZ
|
LY2874455
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
Mebendazole + JQ1
|
DCB3U1E
|
Mebendazole
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Mitomycin + JQ1
|
DCVU9CT
|
Mitomycin
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
MK-2206 + JQ1
|
DCBW51D
|
MK-2206
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
MK-2206 + JQ1
|
DC7FY3J
|
MK-2206
|
Ewing sarcoma (Cell Line: TC-71)
|
[2] |
MLN8237 + JQ1
|
DCSXFFT
|
MLN8237
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
ONC201 + JQ1
|
DCU7KJB
|
ONC201
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Palbociclib + JQ1
|
DCI500M
|
Palbociclib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
PD-0325901 + JQ1
|
DCQSVFV
|
PD-0325901
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
PHA848125 + JQ1
|
DCXU8V3
|
PHA848125
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
PMID25656651-Compound-5 + JQ1
|
DC8FSNM
|
PMID25656651-Compound-5
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[3] |
PMID25656651-Compound-5 + JQ1
|
DCZQUSS
|
PMID25656651-Compound-5
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[3] |
PMID25656651-Compound-5 + JQ1
|
DCBWZAT
|
PMID25656651-Compound-5
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[3] |
Prochlorperazine + JQ1
|
DC4LO0V
|
Prochlorperazine
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
RTB101 + JQ1
|
DC46MY2
|
RTB101
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
RTB101 + JQ1
|
DCG35RB
|
RTB101
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
SCH772984 + JQ1
|
DCRE1S2
|
SCH772984
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[3] |
SCH772984 + JQ1
|
DCBTTPJ
|
SCH772984
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[3] |
SCH772984 + JQ1
|
DC3TIFI
|
SCH772984
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[3] |
Selumetinib + JQ1
|
DC37SQX
|
Selumetinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
THZ1 + JQ1
|
DC4E95Q
|
THZ1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Tosyl-l-arginine methyl ester + JQ1
|
DCNF6GW
|
Tosyl-l-arginine methyl ester
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Trametinib + JQ1
|
DC5SX13
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[3] |
Trametinib + JQ1
|
DC0F9K2
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[3] |
Venglustat + JQ1
|
DCMZKTD
|
Venglustat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|